{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:04:55Z","timestamp":1779807895470,"version":"3.53.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:p>\n                    Diabetic food ulcers (DFU) are a significant complication for patients with type 2 diabetes mellitus. Presepsin is a new biomarker that can offer greater specificity in detecting bacterial infection. So, the study assessed its use in predicting amputation risk in patients with DFU at admission. This prospective study had 2 groups: DFU patients and a control group of type 2 diabetes mellitus patients. DFU patients were staged using the Wagner classification. A presepsin test and review of clinical records were conducted at admission. Seventy-eight patients were included, 49 of whom were male (62.8%). Median age was 70. Sixty-three were in the DFU group, 15 in the control group (no DFU). Increased presepsin levels were observed in patients with DFU, along with elevated C-reactive protein (CRP) and white blood cell (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Patients who underwent amputation procedures had elevated levels of several inflammatory parameters, including procalcitonin, fibrinogen, white blood cell and presepsin, while CRP levels remained unchanged. In regression analysis, the only significant risk factor for severe infection that required amputation was higher Wagner stage. The optimum presepsin cutoff point of\u2005\u2265\u20051020 pg\/mL had the highest sensitivity (100%) and specificity (57.1%) for identifying amputation, with an area under the curve of 0.829 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003). In contrast, CRP, procalcitonin and fibrinogen had unsatisfactory diagnostic capability for amputation, with area under the curve values of 0.674, 0.600, and 0.714 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.111,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.359, and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.050, respectively). Presepsin may serve as an effective marker for severe infection in patients with DFU. Integrating presepsin and clinical score interpretations can predict severe infections requiring amputation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044819","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:04:55Z","timestamp":1759781095000},"page":"e44819","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic value of presepsin for severe diabetic food ulcers: A prospective observational study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4998-5069","authenticated-orcid":false,"given":"Osman","family":"Baspinar","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kayseri City Training and Research Hospital, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-6776","authenticated-orcid":false,"given":"Derya","family":"Kocer","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Kayseri City Training and Research Hospital, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Bakkal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kayseri City Training and Research Hospital, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9259-7024","authenticated-orcid":false,"given":"Oguzhan Sitki","family":"Dizdar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Kayseri City Training and Research Hospital, Kayseri, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260526","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40257-019-00495-x","article-title":"Diabetic foot ulcers: appraising standard of care and reviewing new trends in management.","volume":"21","author":"Aldana","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"R2-20260526","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/iwj.13200","article-title":"Risk factors for the recurrence of diabetic foot ulcers among diabetic patients: a meta-analysis.","volume":"16","author":"Huang","year":"2019","journal-title":"Int Wound J"},{"key":"R3-20260526","doi-asserted-by":"crossref","first-page":"10325","DOI":"10.1038\/s41598-019-46961-8","article-title":"Patients with healed diabetic foot ulcer represent a cohort at highest risk for future fatal events.","volume":"9","author":"Mader","year":"2019","journal-title":"Sci Rep"},{"key":"R4-20260526","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/bmm-2018-0339","article-title":"Wound exudate CXCL6: a potential biomarker for wound healing of diabetic foot ulcers.","volume":"13","author":"Wang","year":"2019","journal-title":"Biomark Med"},{"key":"R5-20260526","doi-asserted-by":"crossref","first-page":"29605","DOI":"10.3402\/dfa.v7.29605","article-title":"Risk factors for occurrence and recurrence of diabetic foot ulcers among Iraqi diabetic patients.","volume":"7","author":"Mohammed","year":"2016","journal-title":"Diabet Foot Ankle"},{"key":"R6-20260526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2014.46.1.1","article-title":"Biomarkers of sepsis.","volume":"46","author":"Cho","year":"2014","journal-title":"Infect Chemother"},{"key":"R7-20260526","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10408363.2013.764490","article-title":"Biomarkers of sepsis.","volume":"50","author":"Faix","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R8-20260526","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s10156-011-0254-x","article-title":"Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.","volume":"17","author":"Shozushima","year":"2011","journal-title":"J Infect Chemother"},{"key":"R9-20260526","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/cc12847","article-title":"Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.","volume":"17","author":"Ulla","year":"2013","journal-title":"Crit Care"},{"key":"R10-20260526","first-page":"e5151","article-title":"Diagnostic value and prognostic use of presepsin versus procalcitonin in sepsis.","volume":"11","author":"Venugopalan","year":"2019","journal-title":"Cureus"},{"key":"R11-20260526","doi-asserted-by":"crossref","first-page":"e030421","DOI":"10.1136\/bmjopen-2019-030421","article-title":"Diagnostic accuracy of presepsin in predicting bacteraemia in elderly patients admitted to the emergency department: prospective study in Japan.","volume":"9","author":"Imai","year":"2019","journal-title":"BMJ Open"},{"key":"R12-20260526","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12185-018-2447-x","article-title":"Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.","volume":"108","author":"Baraka","year":"2018","journal-title":"Int J Hematol"},{"key":"R13-20260526","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jinf.2014.07.024","article-title":"Diagnostic and prognostic potential of presepsin in Emergency Department patients presenting with systemic inflammatory response syndrome.","volume":"69","author":"Rabensteiner","year":"2014","journal-title":"J Infect"},{"key":"R14-20260526","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/jcm13082311","article-title":"The potential role of presepsin in predicting severe infection in patients with diabetic foot ulcers.","volume":"13","author":"Ha","year":"2024","journal-title":"J Clin Med"},{"key":"R15-20260526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1534734614564867","article-title":"Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China.","volume":"14","author":"Jiang","year":"2015","journal-title":"Int J Low Extrem Wounds"},{"key":"R16-20260526","doi-asserted-by":"crossref","first-page":"e006399","DOI":"10.1161\/CIRCOUTCOMES.119.006399","article-title":"Incidence and factors associated with major amputation in patients with peripheral artery disease: insights from the EUCLID trial.","volume":"13","author":"Long","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R17-20260526","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1099\/jmm.0.000278","article-title":"Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.","volume":"65","author":"Leli","year":"2016","journal-title":"J Med Microbiol"},{"key":"R18-20260526","doi-asserted-by":"crossref","first-page":"991","DOI":"10.21037\/jtd-24-1714","article-title":"Presepsin, procalcitonin, interleukin-6, and high-sensitivity C-reactive protein for predicting bacterial DNAaemia among patients with sepsis.","volume":"17","author":"Zhou","year":"2025","journal-title":"J Thorac Dis"},{"key":"R19-20260526","doi-asserted-by":"crossref","first-page":"1320683","DOI":"10.3389\/fimmu.2023.1320683","article-title":"Diagnostic efficacy of serum presepsin for postoperative infectious complications: a meta-analysis.","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"R20-20260526","first-page":"3","article-title":"Procalcitonin as a diagnostic and prognostic marker in diabetic foot infection. A current literature review.","volume":"56","author":"Velissaris","year":"2018","journal-title":"Rom J Intern Med"},{"key":"R21-20260526","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/iwj.12536","article-title":"The role of procalcitonin as a marker of diabetic foot ulcer infection.","volume":"14","author":"Massara","year":"2017","journal-title":"Int Wound J"},{"key":"R22-20260526","first-page":"e81118","article-title":"The relationship between plasma fibrinogen levels and the severity of diabetic foot ulcers in diabetic patients.","volume":"17","author":"Khan","year":"2025","journal-title":"Cureus"},{"key":"R23-20260526","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jtv.2022.05.001","article-title":"C-reactive protein and diabetic foot ulcer infections: a meta-analysis.","volume":"31","author":"Zhang","year":"2022","journal-title":"J Tissue Viability"},{"key":"R24-20260526","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00125-007-0840-8","article-title":"Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.","volume":"51","author":"Jeandrot","year":"2008","journal-title":"Diabetologia"},{"key":"R25-20260526","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jvs.2017.02.060","article-title":"Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.","volume":"67","author":"Umapathy","year":"2018","journal-title":"J Vasc Surg"},{"key":"R26-20260526","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10156-012-0435-2","article-title":"Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.","volume":"18","author":"Endo","year":"2012","journal-title":"J Infect Chemother"},{"key":"R27-20260526","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.transproceed.2013.07.021","article-title":"Pathfast presepsin assay for early diagnosis of bacterial infections in surgical patients: preliminary study.","volume":"45","author":"Novelli","year":"2013","journal-title":"Transplant Proc"},{"key":"R28-20260526","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clinbiochem.2014.02.011","article-title":"Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department.","volume":"47","author":"Romualdo","year":"2014","journal-title":"Clin Biochem"},{"key":"R29-20260526","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-019-0374-4","article-title":"Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis.","volume":"7","author":"Kondo","year":"2019","journal-title":"J Intensive Care"},{"key":"R30-20260526","doi-asserted-by":"crossref","first-page":"954114","DOI":"10.3389\/fmed.2022.954114","article-title":"Performance of presepsin and procalcitonin predicting culture-proven bacterial infection and 28-day mortality: a cross sectional study.","volume":"9","author":"Park","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R31-20260526","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12865-020-00362-z","article-title":"Can presepsin uniformly respond to various pathogens? An in vitro assay of new sepsis marker.","volume":"21","author":"Koizumi","year":"2020","journal-title":"BMC Immunol"},{"key":"R32-20260526","doi-asserted-by":"crossref","first-page":"e0215791","DOI":"10.1371\/journal.pone.0215791","article-title":"Clinical evaluation of presepsin considering renal function.","volume":"14","author":"Miyoshi","year":"2019","journal-title":"PLoS One"},{"key":"R33-20260526","doi-asserted-by":"crossref","first-page":"e0239236","DOI":"10.1371\/journal.pone.0239236","article-title":"Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a meta-analysis.","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:28:18Z","timestamp":1779805698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":33,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044819","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-06-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}